Stocks and Investing Stocks and Investing
Wed, January 18, 2023

Whitney Ijem Initiated (ALNY) at Strong Buy and Held Target at $310 on, Jan 18th, 2023


Published on 2024-10-28 00:58:33 - WOPRAI, Whitney Ijem
  Print publication without navigation


Whitney Ijem of Canaccord Genuity, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Strong Buy and Held Target at $310 on, Jan 18th, 2023.

Whitney has made no other calls on ALNY in the last 4 months.



There are 9 other peers that have a rating on ALNY. Out of the 9 peers that are also analyzing ALNY, 3 agree with Whitney's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $145 on, Monday, November 7th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $210 on, Friday, October 28th, 2022
  • Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $200 on, Monday, October 24th, 2022


These are the ratings of the 6 analyists that currently disagree with Whitney


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $253 on, Friday, December 16th, 2022
  • Patrick Trucchio of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $415 on, Wednesday, November 2nd, 2022
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $270 on, Friday, October 28th, 2022
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $236 on, Friday, October 28th, 2022
  • Maury Raycroft of "Jefferies" Maintained at Strong Buy with Increased Target to $232 on, Monday, October 3rd, 2022
  • Luca Issi of "RBC Capital" Maintained at Buy with Increased Target to $250 on, Tuesday, September 20th, 2022

Contributing Sources